Evidence map›Paper›PMID 37959534›Full record

ArticleMaterials (Basel, Switzerland)2023

Exploration of Methodologies for Developing Antimicrobial Fused Filament Fabrication Parts.

Sotirios Pemas, Eleftheria Xanthopoulou, Zoi Terzopoulou, Georgios Konstantopoulos, Dimitrios N Bikiaris, Christine Kottaridi, Dimitrios Tzovaras, Eleftheria Maria Pechlivani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sotirios PemasCentre for Research and Technology Hellas, Information Technologies Institute, 6th km Charilaou-Thermi Road, 57001 Thessaloniki, Greece.ORCID 0009-0000-4416-0813
Eleftheria XanthopoulouLaboratory of Chemistry and Technology of Polymers and Colors, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-6725-3462
Zoi TerzopoulouLaboratory of Chemistry and Technology of Polymers and Colors, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0001-7935-2145
Georgios KonstantopoulosLaboratory of General Microbiology, Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0009-0006-0260-3923
Dimitrios N BikiarisLaboratory of Chemistry and Technology of Polymers and Colors, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0001-8458-4952
Christine KottaridiLaboratory of General Microbiology, Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-0979-3871
Dimitrios TzovarasCentre for Research and Technology Hellas, Information Technologies Institute, 6th km Charilaou-Thermi Road, 57001 Thessaloniki, Greece.
Eleftheria Maria PechlivaniCentre for Research and Technology Hellas, Information Technologies Institute, 6th km Charilaou-Thermi Road, 57001 Thessaloniki, Greece.ORCID 0000-0001-6385-2815
Aristotle University of Thessaloniki · GRInformation Technologies Institute · GR

Funding

Horizon 2020 PestNu project no.101037128
6 · The paper itself

Abstract

Composite 3D printing filaments integrating antimicrobial nanoparticles offer inherent microbial resistance, mitigating contamination and infections. Developing antimicrobial 3D-printed plastics is crucial for tailoring medical solutions, such as implants, and cutting costs when compared with metal options. Furthermore, hospital sustainability can be enhanced via on-demand 3D printing of medical tools. A PLA-based filament incorporating 5% TiO

Indexed as

3D printingadditive manufacturing (AM)antimicrobial propertiesEscherichia colifilamentfused filament fabrication (FFF)mechanical propertiespoly(lactic acid) (PLA)Staphylococcus aureustitanium dioxide (TiO2)

Identifiers

PMID37959534
PMCPMC10649695
OpenAlexW4388160248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.